Near-Miss ABO-Incompatible Transfusion in a 42-Bed Emergency Department: System Contributors and an Interprofessional Improvement Response
Student Name
School of Nursing and Health Sciences, Capella University
NURS-FPX6016: Quality Improvement of Interprofessional Care
Instructor Name
Month Day, Year
Analysis of a Near-Miss ABO-Incompatible Transfusion
At 1912 on a Friday, a 61-year-old woman arrived in the 42-bed emergency department of a 410-bed level II trauma center with hematemesis and a hemoglobin of 6.2 g/dL. The emergency physician ordered a type and screen and two units of packed red cells. Labels for four patients printed together at the central clerk station at 1918, and the nurse carried the sheet into the treatment area in a scrub pocket. The type and screen tube drawn from the woman in bay 14 at 1926 was labeled with the identifiers of a man in bay 16 who had separate laboratory work pending. At 2004 the transfusion service typed that specimen as group A positive and found a group O positive result on file for the named patient from an admission fourteen months earlier. The technologist held the crossmatch, called the department, and requested recollection under both patients' identifiers.
No incompatible unit reached a patient, which is what makes this a near miss rather than an adverse event, and it is also what makes it easy to file and forget. The interception was not free. The redraw for the woman in bay 14 was collected at 2019 under scanned identifiers, typed as group A positive, and her first unit was issued at 2108, roughly 47 minutes later than the original crossmatch would have allowed, while she continued to bleed at a hemoglobin of 6.2 g/dL. The event was not isolated either. Over the twelve months ending June 30, the transfusion service intercepted 14 mislabeled or wrong-blood-in-tube specimens across 9,318 type and screen specimens, a rate of 1.5 per 1,000. Nine of the 14 originated in the emergency department, which contributed 2,140 of those specimens: 4.2 per 1,000 there against 0.7 per 1,000 everywhere else in the organization.
Analyzing a near miss with the rigor usually reserved for harm is a deliberate choice and the argument this paper makes. Reason (2000) describes recurring error as the product of latent conditions built into a system long before the person at the sharp end touches it, and a near miss exposes those conditions without charging a patient for the lesson. The Joint Commission requires two patient identifiers at specimen collection and holds a separate goal for eliminating transfusion errors caused by misidentification (The Joint Commission, 2024). Both requirements were formally met that evening. The nurse used two identifiers and her competency record was current. What actually held was an accident of history: had the man in bay 16 carried no prior ABO record, nothing between the label sheet in a pocket and the bedside would have stopped a group A unit from being crossmatched for a group O patient.
System Contributors and the Barrier That Was Never Built
Four system conditions produced this event and none of them is a training gap. That framing is not generosity toward staff; it is the position the Institute of Medicine (2000) took when it argued that safe practice comes from designing systems in which errors are hard to commit rather than from asking careful people to be more careful. The first condition is that identification labels print at a central clerk station rather than at the point of collection, so a label exists as a portable object carrying a patient's name before any patient has been identified. A 30-day audit makes the consequence visible: the handheld barcode collection scanner was used in 333 of 812 emergency department draws, or 41 percent, against 96 percent house-wide. A workflow that is faster, permitted, and rewarded will be the workflow used, whatever the policy says.
The second condition is the barrier that was never built. AABB standards direct that a recipient's ABO group be confirmed on a second, separately collected specimen when no prior record exists, precisely because a single specimen cannot detect its own mislabeling (AABB, 2020). This organization has no such policy and relies instead on the historical record check that happened to be available on Friday. Of the 2,140 emergency department type and screen specimens in the review window, 794 came from patients with no prior ABO on file, so 37 percent of the department's transfusion candidates are protected by a barrier that does not apply to them. The third condition is the reporting taxonomy. This event was entered as a laboratory specimen quality issue, routed to laboratory services, closed in eleven days, and never seen by the transfusion committee or the interprofessional safety council.
The fourth condition is accountability divided until it disappears. Specimen collection belongs to emergency nursing, label printing to registration, the scanner fleet to clinical informatics, the type and screen to the transfusion service, and the order to the emergency physician. Every one of those groups met its own standard on Friday. No group owned the interval between the printed label and the sealed tube, which is the only interval in which this error can be made. The point Reason (2000) makes about defense in depth applies directly, because barriers arranged in series fail together when they all sit downstream of the same unowned step. The transfusion service discrepancy check is a sound last defense and a poor only defense: it detects the error after a patient's blood has been misnamed and after the clinical clock has already started.
Evidence-Based Response, Measures, and Interprofessional Accountability
The evidence supports moving identification to the point of collection rather than adding another verification downstream. A systematic review and meta-analysis of barcoding at specimen collection reported consistent reductions in patient and specimen identification errors across settings, with the effect attributed to technology replacing a manual matching step rather than supplementing it (Snyder et al., 2012). That distinction shapes this plan. Adding a second nurse signature to the current process would only produce a second person reading the same pocketed label. Forty-two bedside label printers at approximately $1,100 each, funded from the laboratory capital line already approved for this fiscal year, remove the portable label instead, and the AABB second-determination standard supplies the missing barrier for patients with no history at the price of one additional tube (AABB, 2020).
The response runs as four dated actions with named owners. In weeks 1 and 2, clinical informatics installs bedside label printers in all 42 bays and disables specimen label printing at the clerk station. In weeks 1 through 4, the transfusion service medical director carries a second ABO determination policy to the medical executive committee, covering any patient without a historical type whose transfusion is not an emergency release. In weeks 2 through 8, the patient safety officer adds a transfusion safety category to the reporting taxonomy that routes to the transfusion committee within one business day. In weeks 4 through 12, the emergency nurse manager and the laboratory manager run one shared monthly audit of 100 randomly selected departmental draws and report scan use to both staffs rather than to one (Agency for Healthcare Research and Quality, 2023).
Four measures carry the response, all baselined on the twelve months already described. Wrong-blood-in-tube events per 1,000 emergency department type and screen specimens move from 4.2 toward 1.0 or below within two quarters. Barcode scan use at collection moves from 41 percent of 812 audited draws to 95 percent of the monthly 100-draw sample. Second ABO determination completion for eligible patients moves from unmeasured to 100 percent, reported monthly as a proportion of eligible issues. The fourth is a balancing measure and it is the one that keeps the response honest: median time from transfusion order to unit issue in the department, currently 38 minutes, must not rise. A safety control that quietly adds fifteen minutes to every transfusion in a bleeding patient has traded one harm for another, and the committee reading this analysis should be told so in the same report.
References
AABB. (2020). Standards for blood banks and transfusion services (32nd ed.). AABB.
Agency for Healthcare Research and Quality. (2023). TeamSTEPPS 3.0 pocket guide. U.S. Department of Health and Human Services.
Institute of Medicine. (2000). To err is human: Building a safer health system (L. T. Kohn, J. M. Corrigan, & M. S. Donaldson, Eds.). National Academies Press.
Reason, J. (2000). Human error: Models and management. BMJ, 320(7237), 768-770.
Snyder, S. R., Favoretto, A. M., Derzon, J. H., Christenson, R. H., Kahn, S. E., Shaw, C. S., Baetz, R. A., Mass, D., Fantz, C. R., Raab, S. S., Tanasijevic, M. J., & Liebow, E. B. (2012). Effectiveness of barcoding for reducing patient specimen and laboratory testing identification errors: A Laboratory Medicine Best Practices systematic review and meta-analysis. Clinical Biochemistry, 45(13-14), 988-998.
The Joint Commission. (2024). National patient safety goals effective January 2024: Hospital accreditation program. The Joint Commission.
How this NURS FPX 6016 Assessment 1 example is structured
This NURS FPX 6016 Assessment 1 example is ordered the way a systems analysis has to be argued at the master's level. The first body section puts the event on a clock and then places it inside a twelve-month rate with its denominator, so the reader can see whether one Friday night was an outlier or a pattern. The second section refuses the training-gap finding and works through four system conditions, including the barrier this organization never built and the divided accountability that left the riskiest step unowned. The third section moves from cause to response: evidence first, then dated actions with named owners, then four measures with baselines, one of them a balancing measure. That progression is what separates MSN work in Quality Improvement of Interprofessional Care, as it runs in the Capella University courseroom, from an incident summary.
NURS-FPX6016 Assessment 1 questions, answered
Does NURS FPX 6016 Assessment 1 have to analyze a real event from my workplace?
No, and using one creates a privacy problem you do not need. The instructions accept an event from practice, a courseroom scenario, or a composite you build, as long as no patient, employer, or colleague is identifiable. The paper above uses a composite constructed to carry a complete causal chain, which analyzes far more cleanly than a half-remembered real case.
What is the difference between an adverse event and a near miss for this assessment?
An adverse event reached the patient and caused harm. A near miss was intercepted before it did. Either qualifies, and a near miss is often the stronger choice because the barriers that failed and the one that held are both visible. Analyze it with the same rigor as harm and state plainly what the interception cost in time or resources.
How is a master's level near-miss analysis different from a BSN root-cause analysis?
Scope and accountability. A BSN analysis usually stops at unit process. At the MSN level the paper is expected to reach organizational design, interprofessional ownership, and measurement: which department owns each step, which policy does not exist, how the event was classified and routed, and which measures with baselines would show whether anything changed.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Capella University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.